Related references
Note: Only part of the references are listed.A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response
Philipp Zens et al.
MODERN PATHOLOGY (2021)
The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?
Audrey Frances et al.
MOLECULAR THERAPY (2020)
MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism
Appolinaire A. Olou et al.
ONCOGENE (2020)
Metabolic Plasticity in Chemotherapy Resistance
Maria Andrea Desbats et al.
FRONTIERS IN ONCOLOGY (2020)
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
Ashley Maynard et al.
CELL (2020)
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
Shun-Qing Liang et al.
ONCOGENE (2019)
EMT is associated with an epigenetic signature of ECM remodeling genes
Paul Peixoto et al.
CELL DEATH & DISEASE (2019)
Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549
Colin Charles Tieche et al.
NEOPLASIA (2019)
Uridine as a protector against hypoxia-induced lung injury
Ekaterina V. Rozova et al.
SCIENTIFIC REPORTS (2019)
HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer
Haitang Yang et al.
ONCOGENESIS (2019)
New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
Haitang Yang et al.
FRONTIERS IN ONCOLOGY (2019)
Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment
Yanyun Gao et al.
CANCER CELL INTERNATIONAL (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution
Loukia G. Karacosta et al.
NATURE COMMUNICATIONS (2019)
Adverse prognostic value of PD-L1 expression in primary resected pulmonary squamous cell carcinomas and paired mediastinal lymph node metastases
Manuel D. Keller et al.
MODERN PATHOLOGY (2018)
Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma
Duo Xu et al.
BRITISH JOURNAL OF CANCER (2018)
Come a long way, still a ways to go: from predicting and preventing fluoropyrimidine toxicity to increased efficacy?
Seid Hamzic et al.
PHARMACOGENOMICS (2018)
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer
Siu W. Lam et al.
PHARMACOLOGICAL RESEARCH (2018)
Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
Hamza Mameri et al.
CLINICAL CANCER RESEARCH (2017)
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Elodie M. Kuntz et al.
NATURE MEDICINE (2017)
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge et al.
CANCER DISCOVERY (2017)
A Critical Balance: dNTPs and the Maintenance of Genome Stability
Chen-Chun Pai et al.
GENES (2017)
Mitochondria and cancer chemoresistance
Flora Guerra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2017)
Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT
Colin Charles Tieche et al.
BMC CANCER (2016)
Schedule-dependent increased efficiency of pemetrexed-ionizing radiation combination therapy elicits a differential DNA damage response in lung cancer cells
Patrick Dorn et al.
CANCER CELL INTERNATIONAL (2016)
The role of pharmacogenetics in capecitabine efficacy and toxicity
S. W. Lam et al.
CANCER TREATMENT REVIEWS (2016)
Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs
Jadd Shelton et al.
CHEMICAL REVIEWS (2016)
Migration and invasion of drug-resistant lung adenocarcinoma cells are dependent on mitochondrial activity
Ji Hoon Jeon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
MOLECULAR BIOLOGY Salvaging the genome
Sharanya Sivanand et al.
NATURE (2015)
CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer
Melania Zauri et al.
NATURE (2015)
Targeting mitochondria metabolism for cancer therapy
Samuel E. Weinberg et al.
NATURE CHEMICAL BIOLOGY (2015)
Regulation of mammalian nucleotide metabolism and biosynthesis
Andrew N. Lane et al.
NUCLEIC ACIDS RESEARCH (2015)
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer
S-Q Liang et al.
CELL DEATH & DISEASE (2015)
Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
Rebecca Lamb et al.
ONCOTARGET (2015)
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
B. Besse et al.
ANNALS OF ONCOLOGY (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Hariharan Easwaran et al.
MOLECULAR CELL (2014)
Standing the test of time: targeting thymidylate biosynthesis in cancer therapy
Peter M. Wilson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
COMPARTMENTS: unification and visualization of protein subcellular localization evidence
Janos X. Binder et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2014)
Non-small-cell lung cancers: a heterogeneous set of diseases
Zhao Chen et al.
NATURE REVIEWS CANCER (2014)
TCPA: a resource for cancer functional proteomics data
Jun Li et al.
NATURE METHODS (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts
Motoyuki Kataoka et al.
ONCOLOGY REPORTS (2012)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Inhibition of REV3 Expression Induces Persistent DNA Damage and Growth Arrest in Cancer Cells
Philip A. Knobel et al.
NEOPLASIA (2011)
SENESCENCE Senescence in tumours: evidence from mice and humans
Manuel Collado et al.
NATURE REVIEWS CANCER (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
A comparative analysis of the cell biology of senescence and aging
Eun Seong Hwang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis
Cesar Mendiola et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Spheroid-based drug screen: considerations and practical approach
Juergen Friedrich et al.
NATURE PROTOCOLS (2009)
H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks
Thomas M. Marti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Schedule-dependent interactions between pemetrexed and cisplatin in human carcinoma cell lines in vitro
Y Kano et al.
ONCOLOGY RESEARCH (2006)
Hydrolysis of capecitabine to 5′-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide
SK Quinney et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Pemetrexed: A multitargeted antifolate
KD Rollins et al.
CLINICAL THERAPEUTICS (2005)
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
T Le Chevalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mammalian pyrimidine biosynthesis: Fresh insights into an ancient pathway
DR Evans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
